Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 3/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8187267 | 0.84 | BRD4 (0.42) | CHRM1BRD4 | |
| SCHEMBL5777245 | 0.84 | BRD4 (0.34) | CHRM1CHRM5CHRM3BRD4POLB | |
| SCHEMBL12406710 | 0.83 | CHRM1 (0.33) | CHRM1CHRM5CHRM3BRD4EGFR | |
| SCHEMBL6911403 | 0.79 | SLC5A1 (0.33) | CHRM1CHRM5CHRM3EGFR | |
| SCHEMBL6719202 | 0.77 | EGFR (0.34) | EGFR | |
| SCHEMBL6743760 | 0.77 | PTAFR (0.32) | CHRM1EGFR | |
| SCHEMBL8570945 | 0.75 | SLC5A1 (0.33) | CHRM1EGFR | |
| SCHEMBL39263 | 0.75 | CHRM1 (0.35) | CHRM1CHRM5CHRM3BRD4 | |
| SCHEMBL8177519 | 0.74 | NR3C2 (0.41) | POLB | |
| SCHEMBL25359353 | 0.74 | CHRM1 (0.35) | CHRM1CHRM5CHRM3POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7973219-B2 | Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-05 | — | — | US | disclosed |
| US-7973219-B2 | Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-05 | — | — | US | disclosed |
| US-20100184597-A1 | Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants | NAKAJIMA HIROKI | 2010-07-22 | — | — | US | disclosed |
| US-20100184597-A1 | Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants | NAKAJIMA HIROKI | 2010-07-22 | — | — | US | disclosed |
| US-7485777-B2 | Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-02-03 | — | — | US | disclosed |
| US-7485777-B2 | Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-02-03 | — | — | US | disclosed |
| US-6015774-A | Pyrazin-2-one derivatives, their use, and intermediates for their production | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184597-A1 | Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants | PPOX, HMBS, COX6B1 | CHRM1 4271/4885CHRM5 3720/4885CHRM3 4208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.